English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Mallinckrodt Plc
Press release submission
| Sep 24, 2019
MALLINCKRODT: Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft® Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns
Trending
Patient Daily
| Sep 3, 2025
Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+
Pharmaceuticals
Patient Daily
| Sep 4, 2025
PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+
Pharmaceuticals
Patient Daily
| Sep 2, 2025
Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+
Pharmaceuticals
Patient Daily
| Aug 29, 2025
Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
